612069-27-9Azithromycin EP Impurity E
● In Stock
| Catalogue No.: | VL186007 |
|---|---|
| CAS No.: | 612069-27-9 |
| Mol. Formula: | C36H68N2O12 |
| Mol. Weight: | 720.93 g/mol |
Additional information on CAS 612069-27-9
Parent drug
AzithromycinIUPAC Name
3-(N,N-didemethyl) AzithromycinSynonyms
Amino Azithromycin; (2R, 3S, 4R, 5R, 8R, 10R, 11R, 12S, 13S, 14R)-11-[(3-Amino-3, 4, 6-trideoxy-?-D-xylo-hexopyranosyl)oxy]-13-[(2, 6-dideoxy-3-C-methyl-3-O-methyl-?-L-ribo-hexopyranosyl)oxy]-2-ethyl-3, 4, 10-trihydroxy-3, 5, 6, 8, 10, 12, 14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one; Aminoazithromycin A; Aminoazithromycin Impurity E (EP) ;Azithromycin Impurity E; USP RRT 0.43Characterization Data (Included)
HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, and Structure Elucidation Report (SER).Additional Characterization Data
QNMR, D2O Exchange, 13C NMR, 13C APT, COSY NMR, NOESY NMR, 15N NMR, HSQC NMR, HMQC NMR, and HMBC NMR. These are available upon request and may be free or subject to additional charges.Description
Also known as Azithromycin Impurity E, it is an impurity of Azithromycin. Azithromycin is the first member of a group that belongs to macrolide antibiotics called azalides. It is an effective therapeutic agent for the oral treatment of sexually transmitted diseases, upper and lower respiratory tract infections and skin structure infections.References
Kwiecie?, Anna, et al. Stress Degradation Studies on Azithromycin and Development of a Validated Stability-Indicating TLC-Densitometric Method with HPLC/Electrospray Ionization-MS Analysis of Degradation Products.” Journal of AOAC INTERNATIONAL, vol. 95, no. 5, Sept. 2012, pp. 1418–24, https://doi.org/10.5740/jaoacint.10-196.Request a Quote
« * » indique les champs nécessaires









